Skip to main content
. Author manuscript; available in PMC: 2017 Jul 26.
Published in final edited form as: N Engl J Med. 2015 Apr 1;376(4):330–341. doi: 10.1056/NEJMoa1414216

Figure 2. Antibody Responses to Ebola Glycoprotein.

Figure 2

Individual antibody titers as assessed at 14 and 28 days after vaccination are shown according to vaccine dose group, as measured by an enzyme-linked immunosorbent assay (ELISA) against the Zaire–Kikwit strain glycoprotein (Panel A) and a pseudovirion neutralization assay (Panel B). Geometric mean titers (horizontal lines) are shown for each group and time point. Geometric mean titers from 28 days after initial vaccination through 180 days after initial vaccination are shown for the glycoprotein ELISA (Panel C) and the pseudovirion neutralization assay (Panel D). Solid lines indicate groups that received a second dose at day 28, and dashed lines indicate groups that did not receive a second dose at day 28. In all panels, I bars indicate 95% confidence intervals.